View up-to-date information on Arcutis Biotherapeutics Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| IL295172A | Application | Topical roflumilast formulation having improved delivery and plasma half-life | A61K2300/00; A61K31/44; A61K47/10; A61K9/0014; A61K9/06; A61P17/00; A61P17/04 | September 01, 2022 |
| AU2021214399A1 | Application | Topical roflumilast formulation having improved delivery and plasma half-life | A61K31/44; A61K47/10; A61K9/0014; A61K9/06; A61P17/00; A61P17/04 | August 25, 2022 |
| WO2022169615A1 | Application | ROFLUMILAST FORMULATIONS WITH AN IMPROVED PHARMACOKINETIC PROFILE | A61K31/44; A61K47/06; A61K47/10; A61K47/14; A61K47/24; A61K9/0014; A61K9/06; A61K9/122; A61P11/00; A61P17/00 | August 11, 2022 |
| EP4025214A1 | Application | VERFAHREN ZUM REDUZIEREN VON NEBENWIRKUNGEN BEI DER VERABREICHUNG VON PHOSPHODIESTERASE-4-INHIBITOREN | A61K31/44; A61K45/06; A61K47/10; A61K47/24; A61K9/0014; A61K9/06; A61K9/122; A61P11/06; A61P11/08 | July 13, 2022 |
| US20220211730A1 | Application | TREATMENT OF SKIN CONDITIONS USING HIGH KRAFFT TEMPERATURE ANIONIC SURFACTANTS | A61K31/045; A61K31/122; A61K31/165; A61K31/343; A61K31/436; A61K31/513; A61K31/519; A61K31/52; A61K31/655; A61K31/662; A61K31/683; A61K35/04; A61K38/13; A61K47/06; A61K47/10; A61K47/14; A61K9/0014; A61P17/00 | July 07, 2022 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward